CHE Stock Analysis: Buy, Sell, or Hold?
CHE - Chemed Corporation
$487.89
-4.38 (-0.89%)
▼
5d:
+0.52%
30d:
+15.92%
90d:
+25.87%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Jul 28, 2026
13d
Get Alerted When CHE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CHE shows positive signals but monitor for confirmation. Market pricing in 3.8% growth. Moderate conviction.
💡 BUY OPPORTUNITY: CHE shows positive signals but monitor for confirmation. Market pricing in 3.8% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$623.45
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$387.12
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CHE is currently trading at $487.88, which is considered extended relative to its 30-day fair value range of $432.68 to $480.87. From a valuation perspective, the stock is trading at a premium (Forward PE: 18.3) compared to its historical average (16.4). At these levels, the market is pricing in 3.8% annual earnings growth.
Technical Outlook: Technically, CHE is in a uptrend. The price is approaching resistance at $496.14. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CHE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CHE is in a uptrend. The price is approaching resistance at $496.14. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CHE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$432.68 -
$480.87
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($474.00)
- BULLISH: Expecting earnings turnaround to 3.8% growth with 1.6% revenue growth
Trading Range Analysis
30-Day Trading Range
$432.68 -
$480.87
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$456.27
Resistance Level
$496.15
Current Trend
Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.31
Wall Street Target
$474.00
(-3.7%)
Revenue Growth (YoY)
1.6%
Earnings Growth (YoY)
-0.4%
Profit Margin
10.2%
Valuation Premium vs History
+3.8% premium
PE vs Historical
18.3 vs 16.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.8%
(market-implied from PE analysis)
1-Year Target
$510.98
(+4%)
2-Year Target
$530.39
(+8%)
3-Year Target
$550.55
(+12%)
3-Yr Target (if PE normalizes)
(PE: 18→16)
PE COMPRESSION
$493.07
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 10.4%)
$788.57
(+60%)
Base:
(SPY PE: 18.3, Growth: 10.4%)
$663.00
(+35%)
Bear:
(PE: 15.6, Growth: 10.4%)
$563.55
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 26.67 | Current EPS (TTM): $18.32
Bull Case
$788.65
(+60%)
Analyst growth 46.7%, PE expands to 29.3
Base Case
$716.95
(+46%)
Market implied 46.7%, PE stable at 26.7
Bear Case
$332.24
(-33%)
Severe decline -20.0%, PE contracts to 22.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 14, 2026 1:09 PM ET
Data refreshes hourly during market hours. Next update: 2:09 PM
Data refreshes hourly during market hours. Next update: 2:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CHE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin J Mcnamara
SELL
2000 shares
2026-03-12
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 62 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$494 | 61 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 58 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 53 HOLD |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 64 BUY |